Refractory Rheumatoid Arthritis (RA) Clinical Trials in Tucson, Arizona

AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.